1 Result

People

  1. Brentjens
    Brentjens
  2. Fernandez De Larrea Rodriguez
    Fernandez De Larrea Rodriguez
  3. Masakayan
    Masakayan
  4. Ng
    Ng
  5. Peguero
    Peguero
  6. Purdon
    Purdon
  7. Riviere
    Riviere
  8. Smith
    Smith
  9. Staehr
    Staehr
  10. Wang
    Wang

Groups

  1. Adult Leukemia (1)
  2. Cancer Biology and Genetics Program Faculty (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. GSK Faculty (1)
  6. Hematologic Malignancies Research (1)
  7. Hematologic Malignancies, Division of (1)
  8. Myeloma (1)
  9. Sloan Kettering Institute Faculty (1)
  10. Sloan Kettering Institute Postdocs (1)
  1. "article"
  2. "Myeloma"
  3. "Reed Masakayan"
Formats
  1. Journal Article (1)
Groups
  1. Adult Leukemia (1)
  2. Cancer Biology and Genetics Program Faculty (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. GSK Faculty (1)
  6. Hematologic Malignancies Research (1)

More Groups

People
  1. Carlos Fernandez De Larrea Rodriguez (1)
  2. Elizabeth Peguero (1)
  3. Eric Smith (1)
  4. Hans Wendel (1)
  5. Isabelle Riviere (1)
  6. Khong Ng (1)

More People

Years
  1. 2019 (1)
Publications
  1. Science Translational Medicine (1)
Publishers
  1. American Association for the Advancement of Science (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save